Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lisi Dai
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0000-0002-4027-719X
Observed ORCID:
0000-0002-4027-719X
OpenAlex ID:
A5012048730
Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2023
·
Wenhua Sang
, Yiduo Zhou
, et al.
·
Cancer Discovery
·
68
Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology
2023
·
Junning Ma
, Lisi Dai
, et al.
·
Biomaterials
·
68
Linear ubiquitination regulates the KSHV replication and transcription activator protein to control infection
2024
·
Yi Luan
, Wenying Long
, et al.
·
Nature Communications
·
10
Decoupling actin assembly from microtubule disassembly by TBC1D3C-mediated direct GEF-H1 activation
2024
·
Yi Luan
, Zhifeng Deng
, et al.
·
Life Science Alliance
PDF
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S3 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
SUPPLEMENTARY DATA FIGURES from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
SUPPLEMENTARY DATA FIGURES from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
PDF
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S3 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Show more works
View as search
Works count:
20
Citation count:
146
H-index:
3
I10-index:
3
Year
Topic
Type